Shedding of ctDNA, radiomics assessment of tumor disease volume (TDV), and concordance of mutations (mut) in synchronous liquid and tumor biopsies in metastatic breast cancer (MBC).

Authors

null

Andri Papakonstantinou

Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Group, Vall D´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Andri Papakonstantinou , Alberto Gonzalez-Medina , Judit Matito , Marta Ligero , Fiorella Ruiz-Pace , Anna Suñol , Joaquin Rivero , Roberta Fasani , Mara Cruellas , Vicente Peg , Maria Borrell , Isabel Pimentel , Santiago Escriva De Romani Munoz , Judith Balmana Gelpi , Paolo Nuciforo , Rodrigo Dienstmann , Cristina Saura , Raquel Perez-Lopez , Mafalda Oliveira , Ana Vivancos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Other Breast Cancer Subtypes

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 1086)

DOI

10.1200/JCO.2022.40.16_suppl.1086

Abstract #

1086

Poster Bd #

464

Abstract Disclosures